A comprehensive view of Approval Recommendations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA advisor committee supports conditional clearance of Biogen’s tofersen ALS drug; tofersen treats ALS caused by SOD1 gene mutation, which is estimated to be responsible for less than 500 of the approximately 30,000 ALS cases in the US
Published: March 23, 2023 by BioPharma Dive
FDA briefing document finds clinical trial results of Pfizer’s Paxlovid COVID-19 antiviral pill support drug’s use in high-risk adults; FDA meeting Thursday to discuss recommending full approval of Paxlovid as COVID-19 treatment
Published: March 15, 2023 by Baystreet US News Alerts
FDA advisory committee votes in favor of Roche’s Polivy in combination with four other drugs to treat previously untreated diffuse large B-cell lymphoma; DLBCL is a hard-to-treat disease and is the most common form of non-Hodgkin lymphoma in the US
Published: March 10, 2023 by GlobeNewswire Europe
Novo Nordisk’s prescription Wegovy semaglutide recommended for use in UK’s NHS as a weight-loss aid; drug use limited to two-years as part of weight management program that provides multidisciplinary management of weight or obesity
Published: March 08, 2023 by PharmaTimes
FDA panel backs GSK’s RSV vaccine for Americans 60 years and older; shot lowered risk of symptomatic illness by 83%, risk of severe illness by 94% in clinical trial
Published: March 06, 2023 by Physician's Briefing

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count